The global safety syringe market was valued at US$ 7,416.3 million in 2023 and is expected to reach US$ 12,054.3 million in 2034. The market is expected to surge at a CAGR of 4.5% through 2034. It is anticipated to attain a value of around US$ 7,736.2 million in 2024.
| Attributes | Key Insights |
|---|---|
| Safety Syringe Market Size in 2023 | US$ 7,416.3 million |
| Estimated Safety Syringe Market Value (2024) | US$ 7,736.2 million |
| Forecast Safety Syringe Market Revenue (2034) | US$ 12,054.3 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
Syringes are widely utilized in several medical settings, including hospitals and clinics, for vaccines, insulin administration, and other vital pharmacological therapies. Their uniform design allows healthcare service providers to offer consistent and controlled drug distribution, which improves patient safety and treatment efficacy.
Safety syringes are made with mechanisms that either retract, shield, or deactivate the needle after use to reduce the possibility of unintentional needlestick injuries. These syringes are frequently used in medical settings, such as blood collection, medication delivery, and immunizations.
The market for safety syringes is primarily driven by strict regulatory demands that encourage the use of safety devices, growing worries about the spread of blood-borne illnesses, and growing awareness of needlestick injuries. Continuous technological innovations and developments would aid in the creation of safer, more user-friendly syringes.
Global health initiatives such as immunization campaigns and efforts to combat infectious illnesses influence the need for safe syringes in the market. In the safety syringe industry, trends such as the growing use of self-administration tools, the demand for disposable syringes, and partnerships between significant competitors are driving growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for systematic syringes grew at a CAGR of 4.3% from 2019 to 2023. Several factors, including a greater understanding of the importance of needle stick injury prevention and healthcare worker safety, can be responsible for the rising sales of safety syringes. Healthcare workers who suffer needlestick injuries have a serious risk of contracting bloodborne infections like HIV, hepatitis B, and hepatitis C.
Safety syringes have become an essential device due to the healthcare industry's active search for ways to improve safety precautions. The healthcare industry's growing emphasis on safety at work standards and regulations is one of the key factors driving sales growth.
The usage of safety syringes has also increased due to rising awareness of infectious diseases, specifically in global health emergencies. Notably, the COVID-19 pandemic has highlighted the need for infection control procedures, compelling healthcare professionals to invest in safer medical equipment, such as syringes with enhanced security features.
Technological developments have also resulted in innovative syringe safety features, like automatic safety shields and retractable needles. These characteristics increase the general effectiveness and accessibility of healthcare environments while reducing the probability of needlestick injuries.
Considering the increasing demand for minimally invasive surgeries, technological advancements, and increased awareness of infectious diseases, the growth of safety syringes is anticipated. The global safety syringe market is expected to propel at a CAGR of 4.5% over the forecast period.
Increasing the number of internet users and raising awareness regarding e-commerce for healthcare products are changing the scenario of distribution channels. Several manufacturers are selling their products through e-commerce websites at the country level.
A handful of e-commerce websites strongly focus on disposable products only. Due to the growing usage of online sales, the growth through online sales is increasing and creating opportunities for the market.
Asia Pacific, Latin America, and the Middle East are the emerging markets in the world. Insulin syringes present a higher opportunity for safe syringes for regions with the leading population and diabetic rate in the world.
The healthcare infrastructure is developing with increasing funding and investment in research & development and technology. Hence, the demand for precise and standardized medical equipment is increasing.
Systematic syringes, with their precision in medicine administration, play an essential role in ensuring effective medication delivery. Rising healthcare investments make modern medical tools more affordable, ultimately creating a favorable environment for the market growth of safe syringes.
Principal Consultant
The unauthorized use of safety syringes for illegal purposes is a severe problem when such products are misused. Safety syringe sales for their intended medical uses can drop as a result of unethical users using this product for non-medical purposes, such as the injection of illegal narcotics.
The improper use of safety syringes contradicts the intended usage of these instruments and puts the general public's health at risk. The possibility of needle sharing among drug addicts increases the likelihood of spreading bloodborne pathogens like hepatitis and HIV.
They would add to a more significant public health emergency. Incorrect application of safety syringes has two problems: it reduces the market for appropriate medical usage and makes infectious disease transmission in communities harder. Factors such as the availability of safe syringes in the illegal marketplace and unethical usage of safe syringes could be barriers to the growth of the safe syringe market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of the top five countries. India, China, and the United Kingdom are set to record higher CAGRs of 10.5%, 9.5%, and 2.2%, respectively, through 2034.
| Countries | Value CAGR |
|---|---|
| United States | 1.5% |
| China | 9.5% |
| Germany | 1.8% |
| United Kingdom | 2.2% |
| India | 10.5% |
The United States contributed as the profitable market, holding a global share of around 32.3% in 2023. The United States syringe market is expected to register a CAGR of 1.5% during the forecast period, owing to the rising number of minimally invasive procedures performed in the country.
There is an increasing need for precise and regulated drug administration as these procedures become increasingly common. Safety syringes are essential to the changing landscape of medical treatments in the United States because of the increased attention to patient safety and the efficacy of medication therapy.
China is projected to be the most attractive market globally in 2023, accounting for a market share of around 6.3%. Several factors, such as growing awareness of infectious disorders, a rise in healthcare spending, and the increasing prevalence of chronic disorders, are contributing to significant market growth. The need for safety syringes is further driven by the growing focus on preventative care and early intervention as China's healthcare system changes to meet the demands of an aging population.
Like several other nations, the United Kingdom has laws to encourage the use of safe syringes. Manufacturers and healthcare facilities must adhere to safety regulations and recommendations. There has probably been a rise in the use of safety syringes in the United Kingdom due to growing awareness of the dangers of needlestick injuries and the significance of safety for healthcare workers.
In the United Kingdom, healthcare practices are greatly influenced by the National Health Service (NHS). The NHS's deployment of safety syringes can significantly impact market dynamics. The nation's general attitude toward medical innovation is influencing the adoption of safe syringes with cutting-edge features and technologies.
The uptake of safety syringes is impacted by the condition of the healthcare system, including hospitals and clinics in India. Healthcare facilities with adequate equipment are more likely to incorporate safety syringes into their operations. Initiatives and public health campaigns geared toward lowering needlestick injuries and encouraging the use of safety syringes are fueling market expansion.
The COVID-19 pandemic has increased public knowledge of safe measures in healthcare. The pandemic's influence may have impacted the safety of syringe adoption on the order of importance for safety precautions. Government rules, including procurement procedures and reimbursement policies, are further influencing the safety syringe market in India.
Manufacturers of safe syringes and other medical devices must adhere to strict regulations in Japan. Adherence to safety standards and regulations is essential for market approval and entry. Safety syringe usage is rising in Japan due to increased knowledge about needlestick injury prevention, workplace safety, and healthcare safety.
Due to its aging population, Japan has a significant demand for healthcare services. Two primary drivers driving the market for safe syringes are the state of healthcare and the requirement for safe injection procedures.
The below section shows the retractable segment dominating by product type. It is expected to thrive at a 4.1% CAGR by 2034. Based on application, the subcutaneous segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 3.2% during the forecast period.
| Segment | Value CAGR (2024 to 2034) |
|---|---|
| Subcutaneous (Application) | 3.2% |
| Retractable (Product) | 4.1% |
| Hospitals (End-user) | 2.8% |
| Retail Sales (Distribution Channel) | 3.5% |
The retractable segment accounted for a dominant share of 68.2% in 2023. Due to more safety measures than non-retractable safety syringes, retractable syringes usually have more significant sales.
The design of retractable syringes mechanically pulls the needle back into the barrel after use, lowering the possibility of needlestick injuries and stopping the transmission of diseases. Retractable syringes have become more prevalent in healthcare settings due to their safety benefit, which has expanded their adoption.
The subcutaneous segment is leading the market with a share of 65.7% in 2023. In general, subcutaneous injections are less effective and painful than intramuscular injections, which go deeper into the muscle tissue.
Subcutaneous injections involve injecting medications into the fatty tissue just beneath the skin. Because of their smaller size, patients find subcutaneous injections utilizing systematic syringes more manageable.
Several drugs are designed to be administered subcutaneously, which makes it the preferred approach for a handful of therapeutic applications. Subcutaneous application with systematic syringes is more common due to a mix of patient comfort, convenience of administration, and pharmaceutical requirements.
The hospital segment is a leading end-user of the syringe market, with a 29.8% value share in 2023. The hospital segment leads the periodic syringe sales as the end-user due to the high volume of medical testing.
Safety syringes are necessary in hospitals to ensure proper medicine delivery, patient safety, and therapeutic effectiveness. Hospitals have higher revenues in this market than other end-users, including clinics or research institutions, because of the vital importance of healthcare interventions in these locations.
Leading companies are strategically making acquisitions and developing new products to strengthen their positions. Through acquisitions, businesses can expand their skills, penetrate new markets, and diversify their portfolios.
Ongoing product innovations ensure both innovation and competitiveness at the same time. The dynamic market for safety syringes is promoting growth and sustainability through the ability of key players to meet consumer expectations, adjust to evolving industry trends, and maintain a competitive edge through strategic actions.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 7,736.2 million |
| Forecast Market Size (2034) | US$ 12,054.3 million |
| Projected Growth Rate (2024 to 2034) | 4.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America; Latin America; South Asia and Pacific; East Asia; Western Europe; Eastern Europe; Middle East and Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Chile, the Rest of Latin America, China, Japan, South Korea, India, the Association of Southeast Asian Nations, Australia and New Zealand, the Rest of South Asia and Pacific, Germany, Italy, France, United Kingdom, Spain BENELUX, Nordic Countries, Rest of Western Europe, Russia, Hungary, Poland, Rest of Eastern Europe, Saudi Arabia, Türkiye, South Africa, Other African Union, Rest of Middle East and Africa |
| Key Segments Covered | Product, Application, Distribution Channel, End-user, and Region |
| Key Companies Profiled | Becton, Dickinson and Company; AdvaCare Pharma; Cardinal Health Inc.; DMC Medical Ltd.; Duopross Meditech Corp.; Haiou Medical; Kendall Healthcare; Lifelong Meditech (Group); Medicina (HMC Group); Medline Industries; Nipro Corporation; Numedico; Nemera; Retractable Technologies, Inc.; Revolutions Medical Corporation; Smith’s Medical, Inc. (ICU Medical, Inc.); Sol-Millennium Medical Group; Terumo Corporation; UltiMed, Inc. (Ulticare); Unilife Corporation; B. Braun Melsungen AG; Fresenius Kabi AG; West Pharmaceutical Services, Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities, Trends, Market Dynamics and Challenges, Strategic Growth Initiatives |
The market was worth US$ 7,416.3 million in 2023.
The market is expected to reach US$ 12,054.3 million in 2034.
The global market grew at a CAGR of 4.3% between 2019 and 2023.
The United States contributed US$ 2,393.3 million in 2022.
India is expected to surge at a CAGR of 10.5% by 2034.
The retractable segment held a prominent share of 68.2% in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Development/Innovation Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Regulatory Scenario, By Country 4.3. Technology Evolution 4.4. Reimbursement Landscape 4.5. PESTEL Analysis by Region 4.6. PORTER Analysis 4.7. Value Chain Analysis 4.8. Unmet Needs and Opportunities 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Research and Development Funding Outlook 5.1.3. Global Life Expectancy Outlook 5.1.4. Parent Market Analysis 5.2. Forecast Factors - Relevance and Impact 5.2.1. GDP Growth 5.2.2. Healthcare Spending 5.2.3. Prevalence of Chronic Diseases 5.2.4. COVID-19 Pandemic 5.2.5. Product Adoption Rate 5.2.6. Regulatory Framework 5.2.7. Advancements in Technologies 5.2.8. Cost of Products 5.2.9. Global Vaccination Programs 5.2.10. Key Market Players Revenue Analysis 5.2.11. Recent Key Player Activities 5.2.12. Alternative Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Volume (Units) Analysis, 2019 to 2023 6.2. Current and Future Market Volume (Units) Projections, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market Demand Pricing Analysis 2019 to 2023 and Forecast, 2024 to 2034 7.1. Global Average Pricing Analysis Benchmark 7.2. Regional Pricing Analysis 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 8.1. Historical Market Value (US$ million) Analysis, 2019 to 2023 8.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario-Conservative/Likely/Optimistic 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ million) and Volume (Units) By Product, 2019 to 2023 9.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Product, 2024 to 2034 9.3.1. Retractable 9.3.1.1. Manual Retractable Safety Syringes 9.3.1.2. Automatic Retractable Safety Syringes 9.3.2. Non-retractable 9.3.2.1. Sliding Needle Cover Syringes 9.3.2.2. Sheathing Tube Syringes 9.3.2.3. Hinged Needle Cover Syringes 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) Analysis By Application, 2019 to 2023 10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2024 to 2034 10.3.1. Subcutaneous 10.3.2. Intramuscular 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) By Distribution Channel, 2019 to 2023 11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Distribution Channel, 2024 to 2034 11.3.1. Direct to Customer (DTC) 11.3.2. Retail Sales 11.3.2.1. Retail Pharmacies 11.3.2.2. Drug Stores 11.3.3. Online Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ million) By End User, 2019 to 2023 12.3. Current and Future Market Size (US$ million) Analysis and Forecast By End User, 2024 to 2034 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Long-term Care Facilities 12.3.4. Specialty Clinics 12.3.5. Others 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Region, 2019 to 2023 13.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Region, 2024 to 2034 13.3.1. North America 13.3.2. Latin America 13.3.3. East Asia 13.3.4. South Asia and Pacific 13.3.5. Western Europe 13.3.6. Eastern Europe 13.3.7. Middle East and Africa 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. United States 14.3.1.2. Canada 14.3.1.3. Mexico 14.3.2. By Product 14.3.3. By Application 14.3.4. By Distribution Channel 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By Distribution Channel 14.4.5. By End User 14.5. Market Trends 14.6. PESTEL Analysis 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country Level Analysis and Forecast 14.9.1. United States Market Analysis 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Product 14.9.1.2.2. By Application 14.9.1.2.3. By Distribution Channel 14.9.1.2.4. By End User 14.9.2. Canada Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Product 14.9.2.2.2. By Application 14.9.2.2.3. By Distribution Channel 14.9.2.2.4. By End User 14.9.3. Mexico Market Analysis 14.9.3.1. Introduction 14.9.3.2. Market Analysis and Forecast by Market Taxonomy 14.9.3.2.1. By Product 14.9.3.2.2. By Application 14.9.3.2.3. By Distribution Channel 14.9.3.2.4. By End User 15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Chile 15.3.1.3. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By Distribution Channel 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By Distribution Channel 15.4.5. By End User 15.5. Market Trends 15.6. PESTEL Analysis 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country Level Analysis and Forecast 15.9.1. Brazil Market Analysis 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Product 15.9.1.2.2. By Application 15.9.1.2.3. By Distribution Channel 15.9.1.2.4. By End User 15.9.2. Chile Market Analysis 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Product 15.9.2.2.2. By Application 15.9.2.2.3. By Distribution Channel 15.9.2.2.4. By End User 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product 16.3.3. By Application 16.3.4. By Distribution Channel 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By Distribution Channel 16.4.5. By End User 16.5. Country Level Analysis and Forecast 16.5.1. China Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Application 16.5.1.2.3. By Distribution Channel 16.5.1.2.4. By End User 16.5.2. Japan Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Application 16.5.2.2.3. By Distribution Channel 16.5.2.2.4. By End User 16.5.3. South Korea Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Application 16.5.3.2.3. By Distribution Channel 16.5.3.2.4. By End User 17. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. India 17.3.1.2. ASEAN Countries 17.3.1.3. Australia and New Zealand 17.3.1.4. Rest of South Asia and Pacific 17.3.2. By Product 17.3.3. By Application 17.3.4. By Distribution Channel 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By Distribution Channel 17.4.5. By End User 17.5. Country Level Analysis and Forecast 17.5.1. India Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Application 17.5.1.2.3. By Distribution Channel 17.5.1.2.4. By End User 17.5.2. ASEAN Countries Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Application 17.5.2.2.3. By Distribution Channel 17.5.2.2.4. By End User 17.5.3. Australia and New Zealand Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Application 17.5.3.2.3. By Distribution Channel 17.5.3.2.4. By End User 18. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. Germany 18.3.1.2. Italy 18.3.1.3. France 18.3.1.4. United Kingdom 18.3.1.5. Spain 18.3.1.6. BENELUX 18.3.1.7. Rest of Western Europe 18.3.2. By Product 18.3.3. By Application 18.3.4. By Distribution Channel 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By Distribution Channel 18.4.5. By End User 18.5. Country Level Analysis and Forecast 18.5.1. Germany Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Application 18.5.1.2.3. By Distribution Channel 18.5.1.2.4. By End User 18.5.2. France Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Application 18.5.2.2.3. By Distribution Channel 18.5.2.2.4. By End User 18.5.3. Spain Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Application 18.5.3.2.3. By Distribution Channel 18.5.3.2.4. By End User 18.5.4. Italy Market Analysis 18.5.4.1. Introduction 18.5.4.2. Market Analysis and Forecast by Market Taxonomy 18.5.4.2.1. By Product 18.5.4.2.2. By Application 18.5.4.2.3. By Distribution Channel 18.5.4.2.4. By End User 18.5.5. BENELUX Market Analysis 18.5.5.1. Introduction 18.5.5.2. Market Analysis and Forecast by Market Taxonomy 18.5.5.2.1. By Product 18.5.5.2.2. By Application 18.5.5.2.3. By Distribution Channel 18.5.5.2.4. By End User 18.5.6. United Kingdom Market Analysis 18.5.6.1. Introduction 18.5.6.2. Market Analysis and Forecast by Market Taxonomy 18.5.6.2.1. By Product 18.5.6.2.2. By Application 18.5.6.2.3. By Distribution Channel 18.5.6.2.4. By End User 19. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 19.3.1. By Country 19.3.1.1. Russia 19.3.1.2. Hungary 19.3.1.3. Poland 19.3.1.4. Rest of Eastern Europe 19.3.2. By Product 19.3.3. By Application 19.3.4. By Distribution Channel 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By Distribution Channel 19.4.5. By End User 19.5. Country Level Analysis and Forecast 19.5.1. Russia Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Application 19.5.1.2.3. By Distribution Channel 19.5.1.2.4. By End User 19.5.2. Hungary Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Application 19.5.2.2.3. By Distribution Channel 19.5.2.2.4. By End User 19.5.3. Poland Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Product 19.5.3.2.2. By Application 19.5.3.2.3. By Distribution Channel 19.5.3.2.4. By End User 20. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 20.1. Introduction 20.2. Key Players Analyzed 20.3. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023 20.4. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034 20.4.1. By Country 20.4.1.1. Saudi Arabia 20.4.1.2. Türkiye 20.4.1.3. South Africa 20.4.1.4. North Africa 20.4.1.5. Rest of Middle East and Africa 20.4.2. By Product 20.4.3. By Application 20.4.4. By Distribution Channel 20.4.5. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Product 20.5.3. By Application 20.5.4. By Distribution Channel 20.5.5. By End User 20.6. Country Level Analysis and Forecast 20.6.1. Saudi Arabia Market Analysis 20.6.1.1. Introduction 20.6.1.2. Market Analysis and Forecast by Market Taxonomy 20.6.1.2.1. By Product 20.6.1.2.2. By Application 20.6.1.2.3. By Distribution Channel 20.6.1.2.4. By End User 20.6.2. Türkiye Market Analysis 20.6.2.1. Introduction 20.6.2.2. Market Analysis and Forecast by Market Taxonomy 20.6.2.2.1. By Product 20.6.2.2.2. By Application 20.6.2.2.3. By Distribution Channel 20.6.2.2.4. By End User 20.6.3. South Africa Market Analysis 20.6.3.1. Introduction 20.6.3.2. Market Analysis and Forecast by Market Taxonomy 20.6.3.2.1. By Product 20.6.3.2.2. By Application 20.6.3.2.3. By Distribution Channel 20.6.3.2.4. By End User 20.6.4. North Africa Market Analysis 20.6.4.1. Introduction 20.6.4.2. Market Analysis and Forecast by Market Taxonomy 20.6.4.2.1. By Product 20.6.4.2.2. By Application 20.6.4.2.3. By Distribution Channel 20.6.4.2.4. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Concentration 21.4. Market Presence Analysis 21.4.1. Regional Footprint Analysis 21.4.2. Product Footprint Analysis 21.4.3. Channel Footprint Analysis 22. Competition Analysis 22.1. Competition Benchmarking 22.2. Competition Dashboard 22.3. Key Development Analysis 22.4. Key Promotional Strategies 22.5. Competition Deep Dive 22.5.1. Becton, Dickinson and Company. 22.5.1.1. Overview 22.5.1.2. Product Portfolio 22.5.1.3. Sales Footprint 22.5.1.4. Key Financials 22.5.1.5. Strategy Overview 22.5.1.6. SWOT Analysis 22.5.2. AdvaCare Pharma 22.5.3. Cardinal Health Inc. 22.5.4. DMC Medical Ltd. 22.5.5. Duopross Meditech Corp. 22.5.6. Haiou Medical 22.5.7. Kendall Healthcare 22.5.8. Lifelong Meditech (Group) 22.5.9. Medicina (HMC Group) 22.5.10. Medline Industries 22.5.11. Nipro Corporation 22.5.12. Numedico 22.5.13. Nemera 22.5.14. Retractable Technologies, Inc. 22.5.15. Revolutions Medical Corporation 22.5.16. Smiths Medical, Inc. (ICU Medical, Inc.) 22.5.17. Sol-Millennium Medical Group 22.5.18. Terumo Corporation 22.5.19. UltiMed, Inc. (Ulticare) 22.5.20. Unilife Corporation 22.5.21. B. Braun Melsungen AG, 22.5.22. Fresenius Kabi AG 22.5.23. West Pharmaceutical Services, Inc. 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Safety Syringe Market
